Harnessing Real-World Evidence in Oncology Data Analytics
Cancer treatment advances rapidly, enhancing outcomes. However, as treatments increasingly become complex and specific, healthcare professionals face challenges in treating the disease, and this complexity also hinders market understanding for pharmaceutical companies. How can a complex oncology treatment journey be untangled with the use of Real-World Evidence? How can RWE assist in mapping patient demographics, optimizing patient communication, treatment pathways, and real-world outcomes?
Our experts Michael Pröschel, CEO, iOMEDICO and Christoph Mayer, Account Executive, Temedica will discussed these questions in a 45-minute webinar.
The webinar is held in German.
The experts covered:
What Real-World Data types and sources exist vs what they can do
How Real-World Evidence can be leveraged to understand patient populations, how they are treated today, and should be optimally treated better in the future
How RWE can help to validate treatment outcomes in specific patient cohorts
and many more